Effect of the Postoperative Trendelenburg Position on Chronic Subdural Hematoma Recurrence

Launched by UNIVERSIDAD DE ANTIOQUIA · Mar 27, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how the position a patient is placed in after surgery affects the likelihood of a chronic subdural hematoma (CSH) coming back. A chronic subdural hematoma is a type of bleeding that occurs in the brain, often needing surgery to remove it. In this study, patients who have had surgery for CSH will be randomly assigned to either lie in a special position called the Trendelenburg position (with their legs elevated and head slightly tilted) or lie flat for 24 hours after their operation. The researchers will then check if this position affects the chance of the hematoma returning three months later, as well as how well the patients recover and any side effects they might experience.

To be eligible for this trial, participants must be 18 years or older and need surgery for a symptomatic CSH confirmed by a CT scan. They also need to give informed consent, which means they understand the study and agree to participate. However, individuals who are pregnant, have certain health conditions that could make the Trendelenburg position unsafe, or have previously had similar surgeries may not be able to take part. This study is currently recruiting participants, and it aims to provide valuable insights into improving recovery and reducing the chances of recurrence for patients undergoing this type of surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The study included patients aged 18 years or older who required surgical management of symptomatic CSH confirmed by CT scan and whose informed consent was given by the patient or responsible family member to participate in the study
• Exclusion Criteria:
• • Pregnant or breastfeeding
• • Conditions in which the trendelenburg position might not be safe, such as intracranial hypertension without a drain to allow evacuation of the hematoma, cardiovascular instability (severe heart failure, unstable angina, cardiogenic pulmonary edema), acute respiratory distress syndrome without a secure airway, glaucoma, spinal cord trauma not stabilized with surgery, peripheral vascular disease,
• • History of ipsilateral chronic subdural hematoma drainage, intracranial hypotension syndrome, ventriculoperitoneal shunting
• • Simultaneous participation in any other clinical trial.